The clinical, functional, and radiological effect of long-term used immunosuppressive therapy for post-COVID-19 interstitial lung disease.

PubMed, Journal Year: 2023, Volume and Issue: 40(4), P. e2023049 - e2023049

Published: Dec. 20, 2023

Persistent interstitial lung disease (ILD) after COVID-19 infection can lead to severe loss of respiratory function and a decrease in the quality life. There is no consensus regarding treatment post-COVID-19-ILD. This study aims investigate effectiveness immunosuppressive for this group patients.

Language: Английский

---

Interstitial Lung Diseases and COVID19 Pneumonia

Authorea (Authorea), Journal Year: 2023, Volume and Issue: unknown

Published: Sept. 19, 2023

Language: Английский

---

Interstitial lung diseases and COVID‐19 pneumonia

Journal of Medical Virology, Journal Year: 2023, Volume and Issue: 95(11)

Published: Nov. 1, 2023

Language: Английский

---